In a recent study, CaMKII inhibition led to the generation of M1 type macrophages [37], a classically activated pro-inflammatory macrophage phenotype which produces pro-inflammatory mediators and has anti-tumours activity. The gene discussed is CAMK2G; the disease is neoplasm.